South Korea Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

South Korea Insulin Infusion Pumps Market is segmented by Component (Pump Device, Infusion Set, and Reservoir). The report offers the value (in USD) and Volume (in Units) for the above segments.

South Korea Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

South Korea Insulin Infusion Pump Market Size

South Korea Insulin Infusion Pump Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 18.68 Million
Market Size (2030) USD 22.75 Million
CAGR (2025 - 2030) 4.02 %

Major Players

South Korea Insulin Infusion Pump Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of South Korea Insulin Infusion Pump Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

South Korea Insulin Infusion Pump Market Analysis

The South Korea Insulin Infusion Pump Market size is estimated at USD 18.68 million in 2025, and is expected to reach USD 22.75 million by 2030, at a CAGR of 4.02% during the forecast period (2025-2030).

Diabetes patients are more prone to experience complications if they become infected with a virus. Diabetes was found in 14.6% of H1N1 patients and 54.4% of Middle East respiratory syndrome (MERS-CoV) cases in a previous study. Diabetes, one of the most common comorbidities in COVID-19, was related to higher mortality and morbidity. Diabetes has also been listed as a potential risk factor by the World Health Organisation (WHO) and the Centres for Disease Control and Prevention (CDC). Diabetes, one of the most common comorbidities in COVID-19, has been related to higher mortality and morbidity. Diabetes has also been listed as a potential risk factor by the World Health Organisation (WHO) and the Centres for Disease Control and Prevention (CDC).

According to an academic group's datasheet, one in every seven Koreans over 30 has diabetes, although their illness detection and treatment rates remain poor. Diabetes is more common among adults in South Korea, and its economic cost exceeds general cancer. Diabetes complications or associated comorbidities, as well as hospitalization, incur significant costs. Controlling diabetic complications, using healthcare resources, and reducing the financial burden requires effective strategies. Increased understanding of the scope and specific components of the economic burden of diabetes in Korea is likely to motivate health officials to prioritize the prevention and management of the disease and to devote more healthcare resources to diabetes.

As a result of the reasons above, the studied market is expected to increase throughout the analysis period.

South Korea Insulin Infusion Pump Industry Overview

Due to the existence of only a few big businesses operating internationally and locally, the insulin infusion pump industry is concentrated. The competitive landscape includes examining a few well-known worldwide and local organizations, such as Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care.

South Korea Insulin Infusion Pump Market Leaders

  1. Medtronics

  2. Ascensia Diabetes Care

  3. Insulet Corporation

  4. Tandem Diabetes Care

  5. Ypsomed

  6. *Disclaimer: Major Players sorted in no particular order
South Korea Insulin Infusion Pump Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

South Korea Insulin Infusion Pump Market News

  • May 2023: Medtronic agreed to buy EOFlow, a company based in South Korea that makes a tubeless, disposable insulin pump on a patch. The company will offer a public tender to acquire all of EOFlow's outstanding public shares for 971 billion South Korean won (USD 738 million). The purchase will likely allow Medtronic to compete with Insulet, which has gained market share with its tubeless insulin pumps, and Tandem Diabetes Care, which agreed to buy patch pump maker AMF Medical last year.
  • May 2023: Tandem plotted the late 2023 launch of a slimmed-down insulin pump with Dexcom and Abbott CGM integrations.

South Korea Insulin Infusion Pump Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Insulin Infusion Pump
    • 5.1.1 Insulin Pump Device
    • 5.1.2 Infusion Set
    • 5.1.3 Reservoir

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetic Population
  • 6.2 Type-2 Diabetic Population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Medtronic
    • 7.1.2 Insulet corporation
    • 7.1.3 Ypsomed
    • 7.1.4 Ascensia Diabetes Care
    • 7.1.5 Tandem Diabetes Care
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

South Korea Insulin Infusion Pump Industry Segmentation

An insulin pump delivers insulin to control blood sugar and minimize hypoglycemia's effects. The pump comprises a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. South Korea's insulin infusion pumps market is segmented by component (pump device, infusion set, and reservoir). The report offers the value (USD) and Volume (units) for the above segments.

Insulin Infusion Pump Insulin Pump Device
Infusion Set
Reservoir
Need A Different Region or Segment?
Customize Now

South Korea Insulin Infusion Pump Market Research Faqs

How big is the South Korea Insulin Infusion Pump Market?

The South Korea Insulin Infusion Pump Market size is expected to reach USD 18.68 million in 2025 and grow at a CAGR of 4.02% to reach USD 22.75 million by 2030.

What is the current South Korea Insulin Infusion Pump Market size?

In 2025, the South Korea Insulin Infusion Pump Market size is expected to reach USD 18.68 million.

Who are the key players in South Korea Insulin Infusion Pump Market?

Medtronics, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care and Ypsomed are the major companies operating in the South Korea Insulin Infusion Pump Market.

What years does this South Korea Insulin Infusion Pump Market cover, and what was the market size in 2024?

In 2024, the South Korea Insulin Infusion Pump Market size was estimated at USD 17.93 million. The report covers the South Korea Insulin Infusion Pump Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the South Korea Insulin Infusion Pump Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

South Korea Insulin Infusion Pump Industry Report

Statistics for the 2025 South Korea Insulin Infusion Pump market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. South Korea Insulin Infusion Pump analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.